Circulating periostin as a potential biomarker to predict platinum-resistant epithelial ovarian cancer.

被引：0
|
作者：
Ryner, Lisa [1 ]
Noyes, Amy [1 ]
Nazzal, Denise [1 ]
Vu, Paul [1 ]
Guan, Yinghui [1 ]
Lu, Shan [1 ]
Morimoto, Alyssa [1 ]
Brignoli, Sue [1 ]
Wang, Yulei [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
CLINICAL CANCER RESEARCH | 2016年 / 22卷
关键词：
D O I：
10.1158/1557-3265.OVCA15-B31
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B31
引用
收藏
页数：1
相关论文
共 50 条
  • [21] BEVACIZUMAB IN THE TREATMENT FOR PLATINUM-RESISTANT EPITHELIAL OVARIAN CARCINOMA
    Cuellar Angeles, Flores
    Yanez Elena, Sanchez
    Contreras Josefina, Gonzalez
    ATENCION FARMACEUTICA, 2011, 13 (01): : 8 - +
  • [22] Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
    Zhao, Ling-Qin
    Gao, Wen
    Zhang, Ping
    Zhang, Ying-Li
    Fang, Chen-Yan
    Shou, Hua-Feng
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3739 - 3753
  • [23] Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
    Ling-Qin Zhao
    Wen Gao
    Ping Zhang
    Ying-Li Zhang
    Chen-Yan Fang
    Hua-Feng Shou
    World Journal of Clinical Cases, 2022, 10 (12) : 3739 - 3753
  • [24] A phase II study of ENMD-2076 in platinum-resistant ovarian cancer.
    Matulonis, U.
    Tew, W. P.
    Matei, D.
    Behbakht, K.
    Fleming, G. F.
    Oza, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Combination ATR and PARP inhibitor (CAPRI) for recurrent, platinum-resistant ovarian cancer.
    Shah, Payal D.
    Zarrin, Haley
    Wethington, Stephanie
    Latif, Nawar
    Martin, Lainie
    Rodriguez, Diego
    Elkins, Katie
    Giuntoli, Robert
    Burger, Robert
    Tanyi, Janos
    Morgan, Mark
    Domchek, Susan M.
    Gailliard, Stephanie
    Armstrong, Deborah K.
    Simpkins, Fiona
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 75 - 75
  • [26] Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer
    Gulia, Seema
    Ghosh, Jaya
    Bajpai, Jyoti
    Rath, Sushmita
    Maheshwari, Amita
    Shylasree, T. S.
    Deodhar, Kedar
    Thakur, Meenakshi
    Gupta, Sudeep
    JCO GLOBAL ONCOLOGY, 2020, 6 : 542 - 547
  • [27] ORAL ETOPOSIDE IS ACTIVE AGAINST PLATINUM-RESISTANT EPITHELIAL OVARIAN-CANCER
    HOSKINS, PJ
    SWENERTON, KD
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 60 - 63
  • [28] Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
    Pchejetski, Dmitri
    Alfraidi, Albandri
    Sacco, Keith
    Alshaker, Heba
    Muhammad, Aun
    Monzon, Leonardo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (08) : 1659 - 1671
  • [29] Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives
    Pujade-Lauraine, Eric
    Banerjee, Susana
    Pignata, Sandro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27) : 2437 - +
  • [30] Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
    Dmitri Pchejetski
    Albandri Alfraidi
    Keith Sacco
    Heba Alshaker
    Aun Muhammad
    Leonardo Monzon
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1659 - 1671
12345